Immune system’s toll-like receptor 8 may be SSc therapeutic target

Immune system’s toll-like receptor 8 may be SSc therapeutic target

Activating TLR8, a viral defense mechanism, primes monocytes isolated from the blood of people with scleroderma to produce excess IL-10.
12 hours ago
from: Scleroderma News

Continue reading...
Toll-like receptor 8
More about this
- New approaches to research into systemic sclerosis
TLR8 influences the production of disease-related cytokines. Systemic sclerosis is an autoimmune disease that primarily causes inflammation...
from: Informationsdienst Wissenschaft